Mouse models with induced AKI demonstrate that IL-27 treatment can minimize kidney damage, expressed by less tubular injury, increased production of anti-inflammatory cytokines, and decreased production of TNF-alpha, IL-6, and IL-17A [81]. This evidence concerns the gene IL17A and acute kidney injury.